Showing results (381-390 of 781) with videos related to
Sort By:
Pageof 79
Future Oncology (London, England)|April 3, 2015
The investigational proteasome inhibitor ixazomib for the treatment of multiple myelomaPaul G Richardson, Philippe Moreau, Jacob P Laubach, et al.Current Hematologic Malignancy Reports|October 16, 2012
New proteasome inhibitors in myelomaPanisinee Lawasut, Dharminder Chauhan, Jacob Laubach, et al.Cancer Research|April 17, 2002
S-3-Amino-phthalimido-glutarimide inhibits angiogenesis and growth of B-cell neoplasias in miceSuzanne Lentzsch, Michael S Rogers, Richard LeBlanc, et al.British Journal of Haematology|September 15, 2007
Targeting MEK1/2 blocks osteoclast differentiation, function and cytokine secretion in multiple myelomaIris Breitkreutz, Marc S Raab, Sonia Vallet, et al.Blood|May 16, 2002
Biologic sequelae of nuclear factor-kappaB blockade in multiple myeloma: therapeutic applicationsNicholas Mitsiades, Constantine S Mitsiades, Vassiliki Poulaki, et al.British Journal of Haematology|July 13, 2010
Tanespimycin with bortezomib: activity in relapsed/refractory patients with multiple myelomaPaul G Richardson, Ashraf Z Badros, Sundar Jagannath, et al.The Journal of Pharmacy and Pharmacology|August 21, 2010
JS-K has potent anti-angiogenic activity in vitro and inhibits tumour angiogenesis in a multiple myeloma model in vivoTanyel Kiziltepe, Kenneth C Anderson, Jeffery L Kutok, et al.Blood|June 26, 2004
Targeting mitochondria to overcome conventional and bortezomib/proteasome inhibitor PS-341 resistance in multiple myeloma (MM) cellsDharminder Chauhan, Guilan Li, Klaus Podar, et al.Oncoimmunology|August 18, 2025
CyTOF profiling of bone marrow immune dynamics across myeloma stagesDana Cholujova, Gabor Beke, Lubos Klucar, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 7, 2009
Insulin-like growth factor-1- and interleukin-6-related gene variation and risk of multiple myelomaBrenda M Birmann, Rulla M Tamimi, Edward Giovannucci, et al.Pageof 79